Press release
Deadline on Nov. 21st coming up in Lawsuit for Investors in Fulgent Genetics, Inc. (NASDAQ: FLGT)
A Deadline is coming up on November 21, 2022 in the lawsuit for certain investors in Fulgent Genetics, Inc. (NASDAQ: FLGT).
Investors who purchased shares of Fulgent Genetics, Inc. (NASDAQ: FLGT) have certain options and there are strict and short deadlines running. Deadline: November 21, 2022. NASDAQ: FLGT stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
According to the complaint filed in the U.S. District Court for the Central District of California the plaintiff alleges on behalf of purchasers of Fulgent Genetics, Inc. (NASDAQ: FLGT) common shares between March 22, 2019 and August 4, 2022, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between March 22, 2019 and August 4, 2022, the Defendants made false and/or misleading statements and/or failed to disclose that Fulgent Genetics, Inc had been conducting medically unnecessary laboratory testing, engaging in improper billing practices in relation to laboratory testing, and providing or receiving remuneration in violation of the Anti-Kickback Statute and Stark Law, that accordingly, Fulgent Genetics, Inc was likely to become subject to enhanced legal and regulatory scrutiny, that Fulgent's revenues, to the extent they were derived from the foregoing unlawful conduct, were unsustainable, that the foregoing, once revealed, was likely to subject the Company to significant financial and/or reputational harm, and that as a result, the Company's public statements were materially false and misleading at all relevant times.
Those who purchased shares of Fulgent Genetics, Inc. (NASDAQ: FLGT) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Deadline on Nov. 21st coming up in Lawsuit for Investors in Fulgent Genetics, Inc. (NASDAQ: FLGT) here
News-ID: 2798476 • Views: …
More Releases from Shareholders Foundation
ALERT: Lawsuit filed for Investors who SOLD shares of Sina Corporation (formerly …
An investor, who sold shares of Sina Corporation (formerly NASDAQ: SINA) in the merger between Seina Corporation and TuSimple Holdings, Inc, filed a lawsuit over alleged violations of Federal Securities Laws by Sina Corporation (formerly NASDAQ: SINA in connection with certain allegedly false and misleading statements made.
If you sold a significant amount of shares of Sina Corporation (formerly NASDAQ: SINA) between October 13, 2020 and March 22, 2021, you have…
Lawsuit Alert: Investors who lost money with shares of Fluor Corporation (NYSE: …
An investor, who purchased shares of Fluor Corporation (NYSE: FLR), filed a lawsuit alleged violations of Federal Securities Laws by Fluor Corporation in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Fluor Corporation (NYSE: FLR) have certain options and for certain investors are short and strict deadlines running. Deadline: November 14, 2025. NYSE: FLR investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779…
Investigation announced for Long-Term Investors in shares of Sable Offshore Corp …
An investigation was announced for long-term investors in shares of Sable Offshore Corp. (NYSE: SOC) concerning potential breaches of fiduciary duties by certain directors of Sable Offshore Corp.
Investors who are current long term investors in Sable Offshore Corp. (NYSE: SOC) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in…
Lawsuit filed for Investors who lost money with shares of Lantheus Holdings, Inc …
An investor, who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH), filed a lawsuit over alleged violations of Federal Securities Laws by Lantheus Holdings, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) have certain options and for certain investors are short and strict deadlines running. Deadline: November 10, 2025. NASDAQ: LNTH investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
More Releases for Fulgent
U.S. Genetic Testing Is Booming So Rapidly Growth by 2032 | Fulgent Genetics, My …
The qualitative latest Research report (2025-2032) on the U.S. Genetic Testing Market 2025-2032 by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The report highlights tech innovation, pricing trends, consumer behavior, and investment potential - empowering businesses to make informed, strategic moves.
➤ Request a Sample Copy: https://www.coherentmarketresearch.com/samplepages/140166
Focused…
Bardet-Biedl Syndrome Diagnostics Market Size, Share, Growth Insights and Report …
DataM Intelligence has published a new research report on "Bardet-Biedl Syndrome Diagnostics Market Size 2024". The report explores comprehensive and insightful Information about various key factors like Segmentation, CAGR, business revenue competitive positioning of key companies, investigating elements such as product offerings, pricing strategies, financial performance, product portfolios, growth initiatives, and geographical reach. . The purpose of this report is to provide a telescopic view of the current market size…
Cancer Gene Testing Service Market is Booming Worldwide with Latest Rising Trend …
The Latest research study released by HTF MI "Cancer Gene Testing Service - Global and China Top Players Market with 120+ pages of analysis on business Strategy taken up by key and emerging industry players and delivers know-how of the current market development, landscape, technologies, drivers, opportunities, market viewpoint, and status. Understanding the segments helps in identifying the importance of different factors that aid market growth. Some of the Major…
Hereditary Cancer Testing Market Worth Observing Massive Growth | CellMax Life, …
The global Hereditary Cancer Testing Market was estimated at $3.5 billion in 2022, and is anticipated to hit $10.1 billion by 2030, registering a CAGR of +11% from 2022 to 2030.
Hereditary cancer testing plays a crucial role in identifying individuals who have an increased risk of developing certain types of cancer due to inherited genetic mutations. It helps in identifying individuals who may benefit from early detection, surveillance, or…
Investigation announced for Long-Term Investors in Fulgent Genetics, Inc. (NASDA …
An investigation was announced for long-term investors in shares of Fulgent Genetics, Inc. (NASDAQ: FLGT) concerning potential breaches of fiduciary duties by certain directorsofficers of Fulgent Genetics, Inc.
Investors who are current long term investors in Fulgent Genetics, Inc. (NASDAQ: FLGT) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in…
Lawsuit filed for Investors in shares of Fulgent Genetics, Inc. (NASDAQ: FLGT)
An investor, who purchased shares of Fulgent Genetics, Inc. (NASDAQ: FLGT), filed a lawsuit over alleged violations of Federal Securities Laws by Fulgent Genetics, Inc..
Investors who purchased shares of Fulgent Genetics, Inc. (NASDAQ: FLGT) have certain options and for certain investors are short and strict deadlines running. Deadline: November 21, 2022. NASDAQ: FLGT investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
Temple City based Fulgent…
